GlassScriptPhysician profile
Aisha Maldonado
NPI 1578035903
$4,669.22
in general payments reported to CMS, 2019-2025
27 companies · $2,070 in 2025
The $2,070 reported for 2025 was more than what 94% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.63 · 2022: $665 · 2023: $525 · 2024: $1,382 · 2025: $2,070.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,908 · Gift: $53.66 · Education: $16.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,908.19 |
| Gift | $53.66 |
| Education | $16.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $870.66 | 2021-2025 | Wainua, Farxiga |
| Shockwave Medical, INC | $684.42 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $369.80 | 2023-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $341.18 | 2023-2025 | Jardiance |
| Boston Scientific Corporation | $303.29 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $261.33 | 2022-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $219.79 | 2024-2025 | |
| Scpharmaceuticals INC. | $188.16 | 2023-2025 | |
| Abbott Laboratories | $184.07 | 2022-2024 | Cardiomems |
| Impulse Dynamics (USA) INC. | $147.10 | 2022 | |
| Merck Sharp & Dohme LLC | $143.01 | 2023-2025 | Verquvo |
| Pfizer INC. | $137.26 | 2024-2025 | |
| Bridgebio Pharma, INC. | $115.70 | 2025 | Attruby |
| Cvrx, INC. | $102.68 | 2024-2025 | Barostim Neo System |
| Abiomed | $93.34 | 2024-2025 | Impella |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $89.20 | 2024-2025 | Synergy Ablation System |
| Alnylam Pharmaceuticals INC. | $87.60 | 2024 | Onpattro |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $80.67 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $63.24 | 2025 | |
| Daiichi Sankyo INC. | $39.05 | 2024 | Injectafer |
| Amgen INC. | $28.91 | 2023-2025 | Repatha, Repatha |
| Kiniksa Pharmaceuticals International, Plc | $26.57 | 2024 | Arcalyst |
| Glaxosmithkline, LLC. | $25.25 | 2025 | Arexvy, Shingrix |
| Kiniksa Pharmaceuticals, LTD. | $23.42 | 2023 | Arcalyst |
| Altathera Pharmaceuticals LLC | $14.89 | 2024 | Sotalol Hydrochloride |
| Osprey Medical INC | $14.33 | 2021 | |
| Lilly USA, LLC | $14.30 | 2024 | Zepbound, Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aisha Maldonado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.